These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Early and late rejection and HLA sensitization at the time of heart transplantation in patients bridged with left ventricular assist devices. Gonzalez-Stawinski GV; Atik FA; McCarthy PM; Roselli EE; Hoercher K; Navia JL; Smedira NG; Starling RC; Young JB; Cook DJ Transplant Proc; 2005 Mar; 37(2):1349-51. PubMed ID: 15848717 [TBL] [Abstract][Full Text] [Related]
43. Post-transplant donor-specific antibody production and graft outcome in kidney transplantation: results of sixteen-year monitoring by flow cytometry. Piazza A; Poggi E; Ozzella G; Borrelli L; Scornajenghi A; Iaria G; Tisone G; Adorno D Clin Transpl; 2006; ():323-36. PubMed ID: 18365387 [TBL] [Abstract][Full Text] [Related]
44. Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival. Vlad G; Ho EK; Vasilescu ER; Colovai AI; Stokes MB; Markowitz GS; D'Agati VD; Cohen DJ; Ratner LE; Suciu-Foca N Hum Immunol; 2009 Aug; 70(8):589-94. PubMed ID: 19375470 [TBL] [Abstract][Full Text] [Related]
46. Clinical relevance of pretransplant human leukocyte antigen donor-specific antibodies in renal patients waiting for a transplant: a risk factor. Gupta A; Sinnott P Hum Immunol; 2009 Aug; 70(8):618-22. PubMed ID: 19374932 [TBL] [Abstract][Full Text] [Related]
47. Detection of donor-specific anti-HLA antibodies with flow cytometry in eluates and sera from renal transplant recipients with chronic allograft nephropathy. Martin L; Guignier F; Mousson C; Rageot D; Justrabo E; Rifle G Transplantation; 2003 Jul; 76(2):395-400. PubMed ID: 12883199 [TBL] [Abstract][Full Text] [Related]
48. Immunological monitoring of posttransplant allograft sensitization following living related donor renal transplantation. Panigrahi A; Deka R; Bhowmik D; Tiwari SC; Mehra NK Transplant Proc; 2004 Jun; 36(5):1336-9. PubMed ID: 15251326 [TBL] [Abstract][Full Text] [Related]
49. How much donor human leukocyte antigen-specific antibody is too much for a renal transplant? Vaughan R; Shaw O Transplantation; 2008 Apr; 85(8):1081-2. PubMed ID: 18431224 [No Abstract] [Full Text] [Related]
50. De novo anti-HLA antibody responses after renal transplantation: detection and clinical impact. Seveso M; Bosio E; Ancona E; Cozzi E Contrib Nephrol; 2009; 162():87-98. PubMed ID: 19001816 [TBL] [Abstract][Full Text] [Related]
51. Treatment of acute humoral rejection in kidney transplantation with plasmapheresis. Grandtnerová B; Javorský P; Kolácný J; Hovoricová B; Dĕdic P; Laca L Transplant Proc; 1995 Feb; 27(1):934-5. PubMed ID: 7879238 [No Abstract] [Full Text] [Related]
52. On the detection of anti-HLA antibodies using single antigen bead Luminex assay: lot-to-lot variations in MFI. Friedlander R; Putheti P; Diaz E; Menon A; Ponce B; Muthukumar T; Sharma VK; Dadhania D; Suthanthiran M Transplantation; 2013 Aug; 96(4):e24-6. PubMed ID: 23958886 [No Abstract] [Full Text] [Related]
53. Living donor renal transplantation in the presence of donor-specific human leukocyte antigen antibody detected by solid-phase assay. Phelan D; Mohanakumar T; Ramachandran S; Jendrisak MD Hum Immunol; 2009 Aug; 70(8):584-8. PubMed ID: 19477211 [TBL] [Abstract][Full Text] [Related]
54. Non-HLA antibodies after rejection of HLA identical kidney transplants. Zafar MN; Terasaki PI; Naqvi SA; Rizvi SA Clin Transpl; 2006; ():421-6. PubMed ID: 18365399 [TBL] [Abstract][Full Text] [Related]
55. Monitoring of anti-HLA and anti-Major histocompatibility complex class I related chain A antibodies in living related renal donor transplantation. Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK Transplant Proc; 2007 Apr; 39(3):759-60. PubMed ID: 17445592 [TBL] [Abstract][Full Text] [Related]
56. Eighteen-year follow-up of a retrospective study of HLA antibody on kidney graft survival. Lee PC; Ozawa M; Hung CJ; Lin YJ; Chang SS; Chou TC Transplant Proc; 2009; 41(1):121-3. PubMed ID: 19249493 [TBL] [Abstract][Full Text] [Related]
57. Modulation of anti-HLA antibody production following renal transplantation in sensitised, immunoadsorbed patients. Bevan DJ; Carey BS; Vaughan RW; Fallon M; Higgins RM; Hendry BM; Bewick M Transplant Proc; 1997; 29(1-2):1448. PubMed ID: 9123375 [No Abstract] [Full Text] [Related]
58. Alloantibodies and outcomes of deceased donor kidney allografts. Cinti P; Pretagostini R; Lai Q; Tamburro ML; Rossi M; Poli L; Berloco P Hum Immunol; 2009 Aug; 70(8):651-4. PubMed ID: 19527761 [TBL] [Abstract][Full Text] [Related]
59. The association among C4d staining in renal transplant biopsies, the production of donor-specific HLA antibodies, and graft outcome. Howie AJ Transplantation; 2007 Feb; 83(4):373-4. PubMed ID: 17318067 [No Abstract] [Full Text] [Related]
60. [Anti HLA post-transplant antibodies. A new method of monitorization]. López-Hoyos M; Fernández-Fresnedo G; Pastor JM; Arias M Nefrologia; 2004; 24 Suppl 4():62-6. PubMed ID: 15279389 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]